Latest news with #MedinCell
Yahoo
6 days ago
- Business
- Yahoo
European Growth Companies With High Insider Ownership
As European markets experience a positive upswing, with the STOXX Europe 600 Index climbing on strong corporate earnings and optimism surrounding geopolitical tensions, investors are increasingly looking towards growth companies with high insider ownership as potential opportunities. In this context, stocks where insiders hold significant stakes can be particularly appealing, as they often indicate confidence in the company's future prospects and alignment of interests between management and shareholders. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Pharma Mar (BME:PHM) 11.8% 44.2% MedinCell (ENXTPA:MEDCL) 13.9% 94% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 67.4% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 72.6% CD Projekt (WSE:CDR) 29.7% 39.5% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 213 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's uncover some gems from our specialized screener. 2020 Bulkers Simply Wall St Growth Rating: ★★★★★☆ Overview: 2020 Bulkers Ltd. owns and operates large dry bulk vessels worldwide, with a market cap of NOK 3.11 billion. Operations: The company generates revenue from operating large dry bulk vessels across global markets. Insider Ownership: 11.2% 2020 Bulkers, a company with significant insider ownership, is expected to see earnings grow significantly at 30.9% annually, outpacing the Norwegian market. Despite trading at a substantial discount to its estimated fair value and projecting strong revenue growth of 14.1%, recent financial performance has been weak with declining sales and net income compared to last year. The company's high dividend yield appears unsustainable given current earnings coverage and its elevated debt level poses potential risks. Click to explore a detailed breakdown of our findings in 2020 Bulkers' earnings growth report. Our valuation report here indicates 2020 Bulkers may be undervalued. RaySearch Laboratories Simply Wall St Growth Rating: ★★★★★☆ Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment globally, with a market cap of SEK9.43 billion. Operations: The company's revenue is primarily derived from its Healthcare Software segment, which generated SEK1.25 billion. Insider Ownership: 17.6% RaySearch Laboratories, with high insider ownership, is forecasted to achieve significant earnings growth of 24.9% annually, surpassing the Swedish market. Despite a recent decline in quarterly sales and net income, the company remains focused on innovation and strategic partnerships. Its oncology software solutions like RayStation and RayCare continue to gain traction globally. While trading near industry average valuations, its forward-looking revenue growth is expected at 13.6%, outpacing the broader Swedish market's rate. Delve into the full analysis future growth report here for a deeper understanding of RaySearch Laboratories. Our comprehensive valuation report raises the possibility that RaySearch Laboratories is priced higher than what may be justified by its financials. Nagarro Simply Wall St Growth Rating: ★★★★☆☆ Overview: Nagarro SE, with a market cap of €646.42 million, provides digital product engineering and technology solutions in Germany, the United States, and internationally through its subsidiaries. Operations: Nagarro SE generates its revenue through digital product engineering and technology solutions across Germany, the United States, and other international markets. Insider Ownership: 12.3% Nagarro, with substantial insider ownership, is projected to experience significant earnings growth of 23.6% annually, outpacing the German market. Despite a recent dip in net income for the first half of 2025 and lowered revenue guidance for the year, it trades at good value compared to its peers and below its estimated fair value. The company has been added to key German indices like TECDAX and SDAX, reflecting its solid market position. Click here to discover the nuances of Nagarro with our detailed analytical future growth report. The analysis detailed in our Nagarro valuation report hints at an deflated share price compared to its estimated value. Where To Now? Gain an insight into the universe of 213 Fast Growing European Companies With High Insider Ownership by clicking here. Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OB:2020 OM:RAY B and XTRA:NA9. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
05-08-2025
- Business
- Yahoo
European Growth Stocks With Insider Ownership And 26% Earnings Growth
As European markets grapple with the impact of a disappointing trade deal framework between the U.S. and EU, major indices such as France's CAC 40 and Germany's DAX have seen declines, reflecting broader economic uncertainties. In this environment, growth companies with high insider ownership can offer unique insights into potential resilience and strategic vision, making them noteworthy in discussions about investment opportunities amidst fluctuating market conditions. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 44.2% MedinCell (ENXTPA:MEDCL) 13.9% 94% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 65% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 213 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's review some notable picks from our screened stocks. Admicom Oyj Simply Wall St Growth Rating: ★★★★★☆ Overview: Admicom Oyj provides cloud-based software and business process automation solutions in Finland, with a market cap of €243.33 million. Operations: The company generates revenue of €36.45 million from its software and programming segment. Insider Ownership: 21.7% Earnings Growth Forecast: 26.9% p.a. Admicom Oyj, a Finnish software company, demonstrates strong growth potential with earnings forecasted to grow significantly at 26.9% annually, outpacing the Finnish market. Despite recent quarterly net income declines to €1.29 million from €1.92 million last year, revenue is expected to rise by 6-11% in 2025. The appointment of Henna Kotilainen as Chief Strategy Officer may bolster strategic initiatives. Trading below estimated fair value by 23%, it remains an attractive prospect for growth-focused investors in Europe. Click to explore a detailed breakdown of our findings in Admicom Oyj's earnings growth report. The analysis detailed in our Admicom Oyj valuation report hints at an deflated share price compared to its estimated value. Lime Technologies Simply Wall St Growth Rating: ★★★★★☆ Overview: Lime Technologies AB (publ) offers SaaS-based CRM solutions in the Nordic region and has a market cap of SEK5.01 billion. Operations: The company's revenue primarily comes from selling and implementing CRM software systems, amounting to SEK714.91 million. Insider Ownership: 10.4% Earnings Growth Forecast: 20.8% p.a. Lime Technologies, a Swedish software firm, is poised for growth with earnings forecasted to rise significantly at 20.8% annually, surpassing the Swedish market average. Recent earnings reports show increased net income and revenue compared to the previous year. Insider buying has been more frequent than selling in recent months, reflecting confidence in its prospects. Additionally, Lime is actively seeking acquisitions in CRM and Sportadmin sectors to bolster its expansion strategy further. Navigate through the intricacies of Lime Technologies with our comprehensive analyst estimates report here. The valuation report we've compiled suggests that Lime Technologies' current price could be inflated. Viva Wine Group Simply Wall St Growth Rating: ★★★★☆☆ Overview: Viva Wine Group AB develops, markets, imports, and sells wines with a market cap of SEK3.50 billion. Operations: The company's revenue segments include Ecom at SEK687 million and Nordics at SEK3.50 billion. Insider Ownership: 26.9% Earnings Growth Forecast: 21.5% p.a. Viva Wine Group is positioned for growth with earnings expected to rise significantly at 21.5% annually, outpacing the Swedish market average. The company is actively pursuing acquisitions, recently acquiring Delta Wines to enhance its European presence. Despite a recent dip in quarterly earnings and revenue, Viva's strategy focuses on organic growth and strategic M&A to double net sales. Recent board changes include Marie Nygren's election as director, reflecting ongoing governance adjustments. Dive into the specifics of Viva Wine Group here with our thorough growth forecast report. Our valuation report here indicates Viva Wine Group may be undervalued. Make It Happen Investigate our full lineup of 213 Fast Growing European Companies With High Insider Ownership right here. Ready To Venture Into Other Investment Styles? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include HLSE:ADMCM OM:LIME and OM:VIVA. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-07-2025
- Business
- Yahoo
European Growth Stocks With High Insider Ownership
As European markets experience mixed returns, with the pan-European STOXX Europe 600 Index remaining flat and major indexes like France's CAC 40 and Italy's FTSE MIB showing slight gains, investors are closely monitoring economic indicators such as inflation rates and labor market stability. In this context, growth companies with high insider ownership can present compelling opportunities for investors seeking to align their interests with those of company insiders who have a vested interest in long-term success. Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 44.9% MilDef Group (OM:MILDEF) 13.7% 75.6% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 34.2% Circus (XTRA:CA1) 24.7% 94.8% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ★★★★★☆ Overview: GomSpace Group AB (publ) specializes in manufacturing nanosatellites, components, and turnkey satellite solutions, with a market cap of SEK3.12 billion. Operations: The company generates revenue primarily from its Aerospace & Defense segment, amounting to SEK257.05 million. Insider Ownership: 32.3% Revenue Growth Forecast: 29.2% p.a. GomSpace Group demonstrates strong growth potential with forecasted revenue increasing at 29.2% annually, outpacing the Swedish market. Recent strategic moves include a EUR 19.5 million contract for satellite delivery and a new flexible credit facility from main shareholder Peter Hargreaves, enhancing financial stability and strategic alignment. Despite high share price volatility, insider transactions show more buying than selling recently, reflecting confidence in GomSpace's growth trajectory amidst expanding global demand for its satellite solutions. Delve into the full analysis future growth report here for a deeper understanding of GomSpace Group. Insights from our recent valuation report point to the potential overvaluation of GomSpace Group shares in the market. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Swedencare AB (publ) and its subsidiaries develop, manufacture, market, and sell animal healthcare products for cats, dogs, and horses across North America, Europe, and internationally with a market cap of approximately SEK7.55 billion. Operations: The company's revenue segments are comprised of SEK522.20 million from Europe, SEK701 million from Production, and SEK1.59 billion from North America. Insider Ownership: 11.5% Revenue Growth Forecast: 10.4% p.a. Swedencare exhibits promising growth characteristics with its earnings forecast to increase significantly at 41.9% annually, surpassing the Swedish market average. Recent insider activity indicates more buying than selling, suggesting confidence in the company's future prospects. However, Swedencare's revenue growth is expected to be moderate at 10.4% per year and its return on equity remains low at 3.8%. The company recently reported a slight decline in net income despite increased sales and announced a modest dividend of SEK 0.25 per share. Click here and access our complete growth analysis report to understand the dynamics of Swedencare. Our comprehensive valuation report raises the possibility that Swedencare is priced higher than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★★☆ Overview: Stadler Rail AG is a company that manufactures and sells trains across Switzerland, Germany, Austria, various parts of Europe, the Americas, and CIS countries with a market cap of CHF2.05 billion. Operations: Stadler Rail's revenue is primarily derived from three segments: Rolling Stock at CHF2.74 billion, Service & Components at CHF866.43 million, and Signalling at CHF109.11 million. Insider Ownership: 14.5% Revenue Growth Forecast: 11.9% p.a. Stadler Rail's earnings are projected to grow significantly at 44.5% annually, outpacing the Swiss market. Revenue growth is also expected to exceed the market average at 11.9% per year, though profit margins have decreased from last year. The company's Return on Equity is forecasted to be high in three years, indicating potential for strong future performance. Despite no recent insider trading activity, Stadler Rail trades well below its estimated fair value, suggesting possible undervaluation. Unlock comprehensive insights into our analysis of Stadler Rail stock in this growth report. The valuation report we've compiled suggests that Stadler Rail's current price could be inflated. Dive into all 214 of the Fast Growing European Companies With High Insider Ownership we have identified here. Contemplating Other Strategies? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OM:GOMX OM:SECARE and SWX:SRAIL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
09-07-2025
- Business
- Yahoo
European Growth Companies With High Insider Ownership And Up To 113% Earnings Growth
As the pan-European STOXX Europe 600 Index remains relatively stable amid mixed returns in major stock indexes, investors are closely monitoring economic indicators such as eurozone inflation and labor market trends. In this environment, growth companies with high insider ownership can be particularly appealing, as they often demonstrate strong alignment between management and shareholder interests, potentially leading to robust earnings growth. Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 44.9% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 34.2% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 57.5% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 218 stocks from our Fast Growing European Companies With High Insider Ownership screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Sectra AB (publ) operates in the medical IT and cybersecurity sectors across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market capitalization of approximately SEK68.52 billion. Operations: The company's revenue is primarily derived from Imaging IT Solutions at SEK2.80 billion and Secure Communications at SEK406.96 million, with additional contributions from Business Innovation amounting to SEK90.76 million. Insider Ownership: 16.3% Earnings Growth Forecast: 18.2% p.a. Sectra's growth trajectory is supported by robust insider ownership and strategic expansion in digital pathology and AI-enhanced imaging solutions. Recent contracts with healthcare systems in the US, Canada, and Australia highlight its focus on integrated diagnostics and cloud services, enhancing operational efficiency. Despite moderate insider trading activity recently, Sectra's revenue growth outpaces the Swedish market at 15.3% annually. Earnings are projected to grow faster than the market average at 18.2% per year. Click to explore a detailed breakdown of our findings in Sectra's earnings growth report. According our valuation report, there's an indication that Sectra's share price might be on the expensive side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Landis+Gyr Group AG, along with its subsidiaries, offers integrated energy management solutions to the utility sector across the Americas, Europe, the Middle East, Africa, and the Asia Pacific with a market cap of CHF1.70 billion. Operations: The company's revenue segments include $967.49 million from the Americas, $639.04 million from Europe, the Middle East, and Africa (EMEA), and $158.68 million from the Asia Pacific region. Insider Ownership: 10.8% Earnings Growth Forecast: 113.4% p.a. Landis+Gyr Group's growth potential is underpinned by its expected profitability within three years, surpassing average market growth. While revenue is forecast to grow at 6.7% annually, faster than the Swiss market, recent financials show a net loss of US$150.46 million for the year ended March 2025. The introduction of IoT-certified grid sensors exemplifies innovation in product offerings. Leadership changes include Audrey Zibelman as Chair of the Board, potentially steering strategic direction forward. Click here to discover the nuances of Landis+Gyr Group with our detailed analytical future growth report. Our comprehensive valuation report raises the possibility that Landis+Gyr Group is priced higher than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★☆☆ Overview: VAT Group AG, along with its subsidiaries, specializes in the development, manufacturing, and sale of vacuum and gas inlet valves, multi-valve modules, motion components, and edge-welded metal bellows with a market cap of CHF10.11 billion. Operations: The company's revenue segments are comprised of Valves at CHF842.76 million and Global Service at CHF167.53 million. Insider Ownership: 10.2% Earnings Growth Forecast: 16.9% p.a. VAT Group shows promising growth prospects, with earnings forecasted to grow at 16.92% annually, outpacing the Swiss market's 10.6%. Revenue is also expected to increase by 11.6% per year. Despite recent guidance lowering sales expectations for 2027 to CHF 1.5-1.7 billion, insider ownership remains significant without recent substantial buying or selling activity. Recent board changes and dividend affirmations reflect a stable governance structure amid evolving market conditions and strategic adjustments. Dive into the specifics of VAT Group here with our thorough growth forecast report. Our valuation report here indicates VAT Group may be overvalued. Gain an insight into the universe of 218 Fast Growing European Companies With High Insider Ownership by clicking here. Curious About Other Options? Uncover 17 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OM:SECT B SWX:LAND and SWX:VACN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-06-2025
- Business
- Yahoo
3 European Growth Companies With Insider Ownership Up To 24%
As the European market navigates through geopolitical tensions and economic uncertainties, reflected by the recent declines in major indices like the STOXX Europe 600, investors are increasingly seeking stability and growth potential. In this environment, companies with high insider ownership can be particularly appealing as they often indicate management's confidence in their business prospects. Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Redelfi (BIT:RDF) 12.1% 37.3% Pharma Mar (BME:PHM) 11.8% 44.9% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% KebNi (OM:KEBNI B) 38.3% 67% Elliptic Laboratories (OB:ELABS) 24.4% 79% Diamyd Medical (OM:DMYD B) 11.9% 93% CTT Systems (OM:CTT) 17.5% 34.2% Bonesupport Holding (OM:BONEX) 10.4% 58.6% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 190 stocks from our Fast Growing European Companies With High Insider Ownership screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €940.56 million. Operations: The company's revenue is segmented as follows: €176.26 million from the Americas, €134.84 million from Asia-Pacific, and €220.46 million from EMEA (Europe, Middle East and Africa). Insider Ownership: 12.7% Lectra's recent expansion of its Valia Fashion platform into new markets like Mexico and Brazil underscores its growth strategy in the fashion industry's shift to Industry 4.0. Despite a modest revenue growth forecast of 5.9% annually, Lectra's earnings are expected to grow significantly at 21.42% per year, outpacing the French market average. The company is exploring M&A opportunities to strengthen its position further while trading below estimated fair value, indicating potential for future appreciation. Delve into the full analysis future growth report here for a deeper understanding of Lectra. Our comprehensive valuation report raises the possibility that Lectra is priced lower than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Verve Group SE is a digital media company that provides ad-software solutions in North America and Europe, with a market cap of €528.13 million. Operations: The company's revenue is derived from two main segments: Demand Side Platforms (DSP), generating €117.61 million, and Supply Side Platforms (SSP), contributing €401.53 million. Insider Ownership: 24.5% Verve Group SE's recent financial activities, including a SEK 360.024 million follow-on equity offering and board changes, highlight its dynamic growth strategy. Despite a drop in net income to €0.186 million for Q1 2025, revenue increased to €114.91 million compared to the previous year. The company anticipates annual revenues between €530 million and €565 million for 2025, with substantial insider buying indicating confidence in its growth potential despite volatile share prices and lower profit margins than last year. Take a closer look at Verve Group's potential here in our earnings growth report. According our valuation report, there's an indication that Verve Group's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €1.99 billion. Operations: The company's revenue is divided into two main segments: DACH, generating €2.06 billion, and International, contributing €464.53 million. Insider Ownership: 13.4% Redcare Pharmacy's growth potential is underscored by substantial insider buying, indicating confidence despite a volatile share price. The company reported Q1 2025 sales of €717.29 million, up from €560.22 million the previous year, though it incurred a net loss of €10.82 million. With revenue forecasted to grow at 16% annually and expected profitability within three years, Redcare remains undervalued at 69% below its estimated fair value amid recent board changes enhancing strategic oversight. Click here to discover the nuances of Redcare Pharmacy with our detailed analytical future growth report. The analysis detailed in our Redcare Pharmacy valuation report hints at an inflated share price compared to its estimated value. Unlock more gems! Our Fast Growing European Companies With High Insider Ownership screener has unearthed 187 more companies for you to here to unveil our expertly curated list of 190 Fast Growing European Companies With High Insider Ownership. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTPA:LSS XTRA:M8G and XTRA:RDC. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
